US 11266692
Intracellular genomic transplant and methods of therapy
granted A61KA61K2239/38A61K40/11
Quick answer
US patent 11266692 (Intracellular genomic transplant and methods of therapy) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Mar 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2239/38, A61K40/11, A61K40/22, A61K40/32